Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Lars Dyrskjøt Andersen; Marie Stampe Ostenfeld; Jesper Bertram Bramsen; Asli Silahtaroglu; Philippe Lamy; Ramshanker Ramanathan; Niels Fristrup; Jens Ledet Jensen; Claus Lindbjerg Andersen; Karsten Zieger; Sakari Kauppinen; Benedicte Parm Ulhøi; Jørgen Kjems; Michael Borre; Torben Falck Ørntoft

doi:10.1158/0008-5472.CAN-08-4043

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Lars Dyrskjøt Andersen, Marie Stampe Ostenfeld, Jesper Bertram Bramsen, Asli Silahtaroglu, Philippe Lamy, Ramshanker Ramanathan, Niels Fristrup, Jens Ledet Jensen, Claus Lindbjerg Andersen, Karsten Zieger, Sakari Kauppinen, Benedicte Parm Ulhøi, Jørgen Kjems, Michael Borre, Torben Falck Ørntoft

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

349 Citations (Scopus)

Original language	Danish
Journal	Cancer Research
Volume	69
Issue	11
Pages (from-to)	4851-60
Number of pages	9
ISSN	0008-5472
DOIs	https://doi.org/10.1158/0008-5472.CAN-08-4043
Publication status	Published - 2009

Access to Document

10.1158/0008-5472.CAN-08-4043

Cite this

Andersen, L. D., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A., Lamy, P., Ramanathan, R., Fristrup, N., Jensen, J. L., Andersen, C. L., Zieger, K., Kauppinen, S., Ulhøi, B. P., Kjems, J., Borre, M., & Ørntoft, T. F. (2009). Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Research, 69(11), 4851-60. https://doi.org/10.1158/0008-5472.CAN-08-4043

@article{1684cb0f106549db872fa7550ebdfa6c,

title = "Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.",

author = "Andersen, {Lars Dyrskj{\o}t} and Ostenfeld, {Marie Stampe} and Bramsen, {Jesper Bertram} and Asli Silahtaroglu and Philippe Lamy and Ramshanker Ramanathan and Niels Fristrup and Jensen, {Jens Ledet} and Andersen, {Claus Lindbjerg} and Karsten Zieger and Sakari Kauppinen and Ulh{\o}i, {Benedicte Parm} and J{\o}rgen Kjems and Michael Borre and {\O}rntoft, {Torben Falck}",

year = "2009",

doi = "10.1158/0008-5472.CAN-08-4043",

language = "Dansk",

volume = "69",

pages = "4851--60",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "11",

}

Andersen, LD, Ostenfeld, MS, Bramsen, JB, Silahtaroglu, A, Lamy, P, Ramanathan, R, Fristrup, N , Jensen, JL , Andersen, CL, Zieger, K, Kauppinen, S, Ulhøi, BP, Kjems, J , Borre, M & Ørntoft, TF 2009, 'Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.', Cancer Research, vol. 69, no. 11, pp. 4851-60. https://doi.org/10.1158/0008-5472.CAN-08-4043

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. / Andersen, Lars Dyrskjøt; Ostenfeld, Marie Stampe; Bramsen, Jesper Bertram et al.
In: Cancer Research, Vol. 69, No. 11, 2009, p. 4851-60.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

TY - JOUR

T1 - Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

AU - Andersen, Lars Dyrskjøt

AU - Ostenfeld, Marie Stampe

AU - Bramsen, Jesper Bertram

AU - Silahtaroglu, Asli

AU - Lamy, Philippe

AU - Ramanathan, Ramshanker

AU - Fristrup, Niels

AU - Jensen, Jens Ledet

AU - Andersen, Claus Lindbjerg

AU - Zieger, Karsten

AU - Kauppinen, Sakari

AU - Ulhøi, Benedicte Parm

AU - Kjems, Jørgen

AU - Borre, Michael

AU - Ørntoft, Torben Falck

PY - 2009

Y1 - 2009

U2 - 10.1158/0008-5472.CAN-08-4043

DO - 10.1158/0008-5472.CAN-08-4043

M3 - Tidsskriftartikel

C2 - 19487295

SN - 0008-5472

VL - 69

SP - 4851

EP - 4860

JO - Cancer Research

JF - Cancer Research

IS - 11

ER -